ASPSCR1 and neoplasm: Upregulation of epigenetic and transcriptional regulators such as NPM1, SMARCA4, ASPSCR1-TFE3 and TFEB further suggests that tumor signals drive transcriptional reprogramming of model immune cells, creating a stable pro-oncogenic phenotype.